Fulcrum Acoustic, creators of high-performance professional loudspeaker
technologies, has announced its latest innovative product, the CCX1295 12-Inch
Subcardioid Coaxial Loudspeaker. Unlike conventional loudspeakers that trade off low
frequency (LF) directional control for compact enclosures, Fulcrum’s Passive Cardioid
Technology™ enables the CCX1295 to achieve unprecedented LF/HF control for a
product of its size.
The CCX1295 marks Passive Cardioid Technology’s first application in Fulcrum’s
extensive TQ Install line of versatile installation loudspeakers. Combining the benefits
of this technology with Temporal Equalization (TQ™), the single-amplified CCX1295
delivers impressive LF directional control, improved intelligibility, enhanced sonic
accuracy, and the output capability and pattern control of normal premium 2-way
systems in a considerably lighter and more compact enclosure than those with offset
drivers.”
“The CCX1295 features a single 12-inch 90° x 45° woofer and a 3-inch compression
driver in a compact enclosure designed for permanent installation in a wide range of
applications,” explains Fulcrum Acoustic Co-founder and Vice President of R&D David
Gunness. “This passive subcardioid coaxial loudspeaker provides 9 dB of low-
frequency attenuation in the rear hemisphere. As the first member of our CCX12
family, the CCX1295 will soon be joined by 12-inch models offering a full range of
horn patterns.”
Passive Cardioid Technology was first introduced in Fulcrum’s FL283 Line Array
Module, is the basis for their Cardioid Subwoofers product line, and is a technology
they continuously develop and evolve into new applications.
